CNSX:MMEN

Medmen Enterprises Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume770,154 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Medmen Enterprises (CNSX:MMEN) Vs. THCX, GLH, ACG, HC, BIO, and BBM

Should you be buying MMEN stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Medmen Enterprises, including (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Bio-Rad Laboratories (BIO), and Blueberries Medical (BBM).

Medmen Enterprises (CNSX:MMEN) and (THCX.V) (CVE:THCX) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Analyst Ratings

This is a summary of current recommendations and price targets for Medmen Enterprises and (THCX.V), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medmen Enterprises0000N/A
(THCX.V)0000N/A

Valuation and Earnings

This table compares Medmen Enterprises and (THCX.V)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medmen EnterprisesN/AN/AN/AN/AN/A
(THCX.V)N/AN/AN/AN/AN/A

Profitability

This table compares Medmen Enterprises and (THCX.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medmen EnterprisesN/AN/AN/A
(THCX.V)N/AN/AN/A

Medmen Enterprises (CNSX:MMEN) and 31444 (CNSX:GLH) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Analyst Ratings

This is a summary of current recommendations and price targets for Medmen Enterprises and 31444, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medmen Enterprises0000N/A
314440000N/A

Valuation and Earnings

This table compares Medmen Enterprises and 31444's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medmen EnterprisesN/AN/AN/AN/AN/A
31444N/AN/AN/AN/AN/A

Profitability

This table compares Medmen Enterprises and 31444's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medmen EnterprisesN/AN/AN/A
31444N/AN/AN/A

Medmen Enterprises (CNSX:MMEN) and 438280 (CNSX:ACG) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Profitability

This table compares Medmen Enterprises and 438280's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medmen EnterprisesN/AN/AN/A
438280N/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Medmen Enterprises and 438280, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medmen Enterprises0000N/A
4382800000N/A

Valuation and Earnings

This table compares Medmen Enterprises and 438280's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medmen EnterprisesN/AN/AN/AN/AN/A
438280N/AN/AN/AN/AN/A

Medmen Enterprises (CNSX:MMEN) and 815446 (CNSX:HC) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares Medmen Enterprises and 815446's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medmen EnterprisesN/AN/AN/A
815446N/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and target prices for Medmen Enterprises and 815446, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medmen Enterprises0000N/A
8154460000N/A

Valuation & Earnings

This table compares Medmen Enterprises and 815446's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medmen EnterprisesN/AN/AN/AN/AN/A
815446N/AN/AN/AN/AN/A

Medmen Enterprises (CNSX:MMEN) and Bio-Rad Laboratories (CNSX:BIO) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares Medmen Enterprises and Bio-Rad Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medmen EnterprisesN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and target prices for Medmen Enterprises and Bio-Rad Laboratories, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medmen Enterprises0000N/A
Bio-Rad Laboratories0000N/A

Valuation & Earnings

This table compares Medmen Enterprises and Bio-Rad Laboratories' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medmen EnterprisesN/AN/AN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A

Medmen Enterprises (CNSX:MMEN) and Blueberries Medical (CNSX:BBM) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares Medmen Enterprises and Blueberries Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medmen EnterprisesN/AN/AN/A
Blueberries MedicalN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and target prices for Medmen Enterprises and Blueberries Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medmen Enterprises0000N/A
Blueberries Medical0000N/A

Valuation & Earnings

This table compares Medmen Enterprises and Blueberries Medical's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medmen EnterprisesN/AN/AN/AN/AN/A
Blueberries MedicalN/AN/AN/AN/AN/A


Medmen Enterprises Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
THCX
(THCX.V)
0.6$5.30flatC$0.00N/A0.00High Trading Volume
GLH
31444
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ACG
438280
0.6N/AN/AC$0.00N/A0.00Gap Down
HC
815446
0.5N/AN/A$0.00N/A0.00Gap Down
BIO
Bio-Rad Laboratories
0.5N/AN/A$0.00N/A0.00High Trading Volume
BBM
Blueberries Medical
0.6N/AN/A$0.00N/A0.00High Trading Volume
LOVE
Cannara Biotech
0.7N/AN/A$0.00N/A0.00High Trading Volume
CALI
China Auto Logistics
1.3N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
MJ
ETFMG Alternative Harvest ETF
0.5N/AN/A$0.00N/A0.00Gap Down
BOSS
Global X Founder-Run Companies ETF
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LHS
Liberty Health Sciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LIB
Liberty Leaf
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
RQB
Ravenquest Biomed
0.6N/AN/A$0.00N/A0.00High Trading Volume
TGIF
SoFi Weekly Income ETF
0.6N/AN/A$0.00N/A0.00High Trading Volume
Valeant Pharmaceuticals International logo
VRX
Valeant Pharmaceuticals International
0.5N/AN/AC$0.00N/A0.00
VRT
Vertiv
0.5N/AN/A$0.00N/A0.00Gap Down
This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.